pneumonia
seriou
problem
worldwid
recent
demonstr
innat
defens
mechan
lung
highli
induc
pneumococc
pneumonia
determin
breadth
protect
confer
stimul
lung
mucos
innat
immun
identifi
cell
signal
pathway
activ
treatment
mice
treat
aerosol
bacteri
lysat
challeng
lethal
dose
bacteri
fungal
pathogen
mice
highli
protect
broad
array
gramposit
gramneg
class
bioterror
bacteri
pathogen
fungal
pathogen
aspergillu
fumigatu
protect
associ
rapid
pathogen
kill
within
lung
effect
recapitul
vitro
use
respiratori
epitheli
cell
line
gene
express
analysi
lung
tissu
show
mark
activ
nfkb
type
ii
ifn
antifung
pathway
cytokin
strongli
induc
gene
inflammatori
cytokin
tnf
requir
protect
lungexpress
antimicrobi
peptid
also
highli
upregul
taken
togeth
stimul
innat
resist
appear
occur
activ
multipl
host
defens
signal
pathway
lung
epitheli
cell
induc
rapid
pathogen
kill
confer
broad
protect
virul
bacteri
fungal
pathogen
augment
innat
antimicrobi
defens
lung
might
therapeut
valu
protect
patient
neutropenia
impair
adapt
immun
opportunist
pneumonia
defens
immunocompet
subject
bioterror
threat
epidem
respiratori
infect
pneumonia
seriou
problem
worldwid
recent
demonstr
innat
defens
mechan
lung
highli
induc
pneumococc
pneumonia
determin
breadth
protect
confer
stimul
lung
mucos
innat
immun
identifi
cell
signal
pathway
activ
treatment
mice
treat
aerosol
bacteri
lysat
challeng
lethal
dose
bacteri
fungal
pathogen
mice
highli
protect
broad
array
gramposit
gramneg
class
bioterror
bacteri
pathogen
fungal
pathogen
aspergillu
fumigatu
protect
associ
rapid
pathogen
kill
within
lung
effect
recapitul
vitro
use
respiratori
epitheli
cell
line
gene
express
analysi
lung
tissu
show
mark
activ
nfkb
type
ii
ifn
antifung
pathway
cytokin
strongli
induc
gene
inflammatori
cytokin
tnf
requir
protect
lungexpress
antimicrobi
peptid
also
highli
upregul
taken
togeth
stimul
innat
resist
appear
occur
activ
multipl
host
defens
signal
pathway
lung
epitheli
cell
induc
rapid
pathogen
kill
confer
broad
protect
virul
bacteri
fungal
pathogen
augment
innat
antimicrobi
defens
lung
might
therapeut
valu
protect
patient
neutropenia
impair
adapt
immun
opportunist
pneumonia
defens
immunocompet
subject
bioterror
threat
epidem
respiratori
infect
keyword
innat
immun
pneumonia
immunocompromis
host
lung
epithelium
among
healthi
immunosuppress
peopl
pneumonia
lead
caus
prematur
death
world
nosocomi
pneumonia
result
death
hospit
infect
impos
particular
burden
immunocompromis
patient
hematolog
malign
other
undergo
cytotox
therapi
lower
respiratori
tract
also
frequent
locu
emerg
infect
sever
acut
respiratori
syndrom
epidem
influenza
difficult
manag
pathogen
multipl
drug
resist
pseudomona
aeruginosa
extens
drug
resist
mycobacterium
tuberculosi
furthermor
respiratori
rout
like
portal
entri
bioterror
agent
mean
pathogen
deliv
success
modern
era
ie
inhal
anthrax
although
need
ga
exchang
leav
lung
structur
vulner
infect
success
contain
elimin
pathogen
airway
alveolar
epithelia
particular
critic
prevent
infect
capac
recruit
leukocyt
initi
antimicrobi
innat
immun
respons
recent
found
stimul
lung
innat
immun
mechan
aerosol
bacteri
lysat
confer
high
level
protect
challeng
otherwis
lethal
inocula
streptococcu
pneumonia
pretreat
lysat
induc
complet
protect
challeng
given
hour
challeng
lesser
level
protect
occur
shorter
longer
interv
treatment
challeng
protect
occur
even
treatment
follow
challeng
protect
depend
recruit
neutrophil
resid
mast
cell
alveolar
macrophag
specif
airway
rout
infect
surviv
benefit
correl
magnitud
time
rapid
bacteri
kill
within
lung
associ
increas
concentr
numer
antimicrobi
polypeptid
lung
line
fluid
term
protect
phenomenon
stimul
innat
resist
stir
contrast
highli
refin
epitop
sens
adapt
immun
respons
innat
immun
reli
rapid
recognit
pathogenassoci
molecular
pattern
pamp
share
across
mani
pathogen
speci
suppress
adapt
immun
hematopoiesi
observ
hematolog
malign
andor
cytotox
chemotherapi
obviat
lung
innat
immun
respons
pamp
rather
profoundli
immunosuppress
patient
gener
remark
cytokin
respons
pneumonia
shown
pneumonia
result
signific
worldwid
mortal
stimul
antimicrobi
signal
induc
broad
protect
respiratori
pathogen
novel
scientif
clinic
implic
protect
opportunist
bioterror
epidem
infect
receiv
origin
form
juli
final
form
march
innat
lung
defens
highli
induc
mice
receiv
myeloabl
chemotherapi
characterist
breadth
innat
immun
complex
lysat
use
stimul
protect
pneumonia
surviv
effect
induc
aerosol
bacteri
lysat
might
expect
extend
bacteri
pathogen
even
microbi
class
test
hypothesi
treat
mice
lysat
challeng
numer
respiratori
pathogen
includ
nosocomi
pathogen
nation
institut
allergi
infecti
diseas
class
bioterror
agent
find
dramat
protect
divers
bacteri
fungal
pathogen
effect
appear
aris
simultan
induct
multipl
antimicrobi
pathway
epithelium
find
could
provid
basi
novel
clinic
strategi
protect
immunosuppress
patient
fatal
infecti
complic
safeguard
broader
popul
emerg
infect
bioterror
assault
nontyp
haemophilu
influenza
nthi
store
grown
harvest
previous
describ
current
work
cell
pellet
wash
resuspend
ml
sodium
chlorid
solut
suspens
pass
three
time
emulsiflex
cell
disruptor
avestin
ottawa
canada
greater
psi
dilut
mgml
sodium
chlorid
solut
bicinchonin
assay
pierc
rockford
il
centrifug
g
minut
supernat
collect
protein
concentr
adjust
mgml
lysat
steril
passag
filter
frozen
ml
aliquot
treatment
mice
aerosol
lysat
perform
previous
describ
experi
pneumonia
p
aeruginosa
staphylococcu
aureu
aspergillu
fumigatu
conduct
anderson
cancer
center
use
specif
pathogenfre
femal
balbc
mice
harlan
indianapoli
except
experi
litterm
mice
either
sex
bred
within
coloni
use
week
age
experi
bacillu
anthraci
yersinia
pesti
francisella
tularensi
conduct
univers
texa
medic
branch
galveston
use
femal
swisswebst
mice
tacon
hudson
ny
mice
handl
accord
institut
anim
care
use
committe
institut
kill
distress
clinic
pathogen
challeng
target
inocula
induc
mortal
ld
ld
pneumonia
serotyp
p
aeruginosa
strain
klebsiella
pneumonia
serotyp
suspend
pb
deliv
aerosol
use
aeromist
nebul
driven
lmin
co
air
minut
similar
nthi
lysat
exposur
except
addit
ml
bacteri
suspens
ad
nebul
minut
addit
ml
place
begin
total
ml
deliv
pantonvalentin
leukocidin
pvl
toxinproduc
methicillinresist
aureu
suspend
pb
ml
instil
left
nari
mice
anesthet
intraperiton
inject
tribromoethanol
mlg
bioterror
pathogen
dose
target
ld
ame
strain
b
anthraci
spore
pesti
f
tularensi
schu
deliv
nasal
instil
mice
anesthet
intraperiton
inject
ketamin
mgkg
xylazin
mgkg
suspend
vertic
upper
incisor
ml
pathogen
suspens
instil
nari
follow
ml
pb
nari
surviv
studi
perform
use
group
mice
per
condit
conidia
strain
store
frozen
stock
conidiaml
glycerol
pb
aliquot
stock
plate
yeast
extract
agar
plate
co
day
harvest
gentl
scrape
pb
contain
suspens
filter
filter
centrifug
g
minut
wash
resuspend
pb
aerosol
pneumonia
challeng
conidia
count
nebul
suspens
determin
use
hemacytomet
mice
immunosuppress
intraperiton
inject
cyclophosphamid
mggm
cortison
acet
mgkg
day
day
challeng
fumigatu
assess
lung
fungal
burden
hour
challeng
realtim
quantit
pcr
fumigatu
rrna
perform
previous
describ
aspergillu
galactomannan
measur
singleincub
sandwich
elisa
detail
onlin
supplement
mice
treat
aerosol
nthi
lysat
kill
hour
reduc
leukocyt
lung
vasculatur
perfus
airway
lavag
pb
lung
homogen
total
rna
isol
crna
synthes
amplifi
label
hybrid
sentrix
express
beadchip
illumina
san
diego
ca
primari
microarray
data
deposit
nation
center
biotechnolog
inform
gene
express
omnibu
geo
http
wwwncbinlmnih
govgeo
access
number
consist
minimum
inform
microarray
experi
standard
analyz
use
anovabas
scheme
quantil
normal
sampl
condit
follow
pathway
analysi
use
multipl
strategi
describ
materi
method
onlin
supplement
lung
lavag
cell
count
bronchoalveolar
lavag
bal
cytokin
elisa
perform
previous
describ
histolog
analysi
aorta
anesthet
mice
transect
lung
perfus
situ
pb
via
right
cardiac
ventricl
fix
paraformaldehyd
phosphat
buffer
ph
infus
tracheal
cannula
cm
h
pressur
lung
remov
thorac
caviti
fix
overnight
serial
dehydr
embed
paraffin
section
stain
light
microscopi
hematoxylin
eosin
gomori
methanamin
silver
pathogen
bacteri
concentr
nebul
nasal
instil
lung
tissu
determin
plate
serial
dilut
experi
involv
antitnf
antibodi
mice
inject
mg
ratmous
chimer
monoclon
antibodi
centocor
horsham
pa
ml
pb
hour
nthi
lysat
treatment
indic
tnf
block
efficaci
confirm
prevent
tnfinduc
neutrophil
infiltr
intranas
instil
recombin
mous
tnf
peprotech
rocki
hill
nj
previous
describ
murin
lung
epitheli
cell
cultur
sixwel
plate
cellswel
rpmi
supplement
fc
penicillinstreptomycin
grown
confluenc
media
chang
serumand
antibioticfre
rpmi
cell
treat
nthi
lysat
concentr
mgml
hour
inocul
cfu
pneumonia
serotyp
b
anthraci
stern
spore
pathogen
burden
assess
hour
infect
serial
dilut
cultur
media
altern
well
without
cell
infect
without
addit
nthi
lysat
demonstr
absenc
intrins
antibiot
effect
lysat
character
respons
treatment
investig
differenti
gene
express
isol
epitheli
cell
analysi
perform
ident
wholelung
studi
harvest
total
rna
cell
hour
treatment
mgml
nthi
lysat
equal
volum
pb
wholelung
studi
primari
data
deposit
nation
center
biotechnolog
inform
geo
access
number
summari
statist
bacteri
count
lung
tissu
compar
use
student
test
proport
mice
surviv
pathogen
challeng
compar
use
fisher
exact
text
logrank
comparison
surviv
distribut
perform
use
kaplanmei
estim
data
shown
repres
least
two
independ
experi
combin
analysi
differ
microbi
challeng
dose
analys
perform
use
sasstat
sa
institut
cari
nc
given
strike
protect
confer
pneumonia
nthi
lysat
characterist
breadth
innat
immun
respons
test
whether
stimul
aerosol
nthi
lysat
protect
addit
bacteri
pathogen
gramneg
bacilli
p
aeruginosa
k
pneumonia
import
caus
pneumonia
hospit
immunocompromis
patient
gramposit
methicillinresist
aureu
express
pantonvalentin
leukocidin
highli
virul
bacterium
caus
sever
pneumonia
commun
hospit
aerosol
nthi
lysat
hour
bacteri
challeng
provid
nearli
complet
protect
lethal
aerosol
p
aeruginosa
k
pneumonia
intranas
instil
aureu
figur
left
pretreat
nthi
lysat
result
rapid
kill
three
bacteri
speci
within
lung
figur
right
similar
prior
observ
pneumonia
nthi
lysateinduc
reduct
lung
pathogen
burden
immedi
infect
associ
clearanc
pathogen
lung
surviv
wherea
shamtreat
mice
experienc
progress
lung
infect
sepsi
see
tabl
onlin
supplement
observ
protect
highli
pathogen
gramposit
gramneg
clinic
organ
suggest
protect
might
also
extend
agent
bioterror
b
anthraci
like
agent
use
bioterror
attack
highli
virul
avail
infect
soil
worldwid
spore
stabl
readili
aerosol
intranas
instil
ld
b
anthraci
ame
strain
spore
caus
mortal
mice
receiv
nthi
lysat
pretreat
mortal
pretreat
mice
figur
left
protect
associ
signific
reduct
lung
bacteri
cfu
even
though
b
anthraci
deliv
spore
howev
degre
reduct
less
bacteria
figur
right
pretreat
aerosol
nthi
lysat
similarli
reduc
mortal
lung
bacteri
burden
intranas
instil
ld
pesti
figur
nthi
lysat
pretreat
also
increas
time
median
mortal
reduc
lung
bacteri
burden
f
pathogen
burden
measur
hour
challeng
due
small
inocula
mice
observ
least
day
beyond
period
shown
addit
mortal
observ
experi
surviv
significantli
better
nthi
lysatetr
mice
last
day
observ
mortal
p
n
mice
per
group
surviv
studi
except
f
tularensi
p
nthi
lysatetr
mice
experi
includ
f
tularensi
show
greater
kaplanmeierestim
median
surviv
p
compar
shamtreat
mice
lung
pathogen
burden
report
mean
p
p
n
mice
per
group
bacteri
count
intranas
instil
ld
f
tularensi
although
significantli
reduc
overal
mortal
intracellular
pathogen
figur
depend
length
potenti
exposur
infecti
threat
time
cours
bacteri
protect
confer
stir
may
necessit
repetit
treatment
atrisk
popul
consist
recent
report
find
stimul
resist
influenza
viru
multipl
treatment
tachyphylaxi
bacterialprotect
effect
observ
repetit
treatment
whether
mice
expos
multipl
treatment
week
weekli
treatment
week
observ
robust
protect
bacteri
pathogen
figur
next
test
whether
nthi
lysateinduc
protect
would
extend
nonbacteri
pathogen
pneumonia
due
fumigatu
import
caus
mortal
immunocompromis
patient
protect
fungu
test
mice
immunosuppress
experienc
mortal
aerosol
inoculum
conidiaml
data
shown
mice
immunosuppress
cyclophosphamid
cortisol
experienc
approxim
mortal
figur
pretreat
nthi
lysat
reduc
mortal
less
figur
use
quantit
galactomannan
assay
figur
quantit
rtpcr
assay
aspergillu
rrna
figur
lung
pathogen
burden
found
reduc
approxim
day
infect
histopatholog
evalu
unpretr
immunosuppress
mice
demonstr
abund
hyphal
element
extens
tissu
invas
hour
challeng
contrast
nthi
lysatepretr
mice
demonstr
fungal
form
littl
inflamm
figur
suggest
similar
protect
bacteria
nthi
lysatestimul
protect
fungu
aris
primarili
induct
microbicid
environ
rather
gener
cellular
inflamm
challeng
p
aeruginosa
cfuml
swisswebst
mice
treat
nthi
lysat
day
infect
day
infect
pb
alon
b
mice
treat
eight
weekli
nthi
lysat
treatment
one
treatment
pb
challeng
p
aeruginosa
cfuml
n
micegroup
p
p
compar
nthi
gain
insight
mechan
protect
confer
stir
compar
gene
express
profil
treat
untreat
lung
maxim
protect
pneumonia
achiev
hour
treatment
gene
express
pattern
examin
within
interv
mice
expos
aerosol
nthi
lysat
minut
kill
hour
previous
shown
alveolar
macrophag
recruit
neutrophil
dispens
stir
sought
maxim
abil
detect
gene
express
chang
lung
parenchyma
lung
lavag
remov
alveolar
macrophag
leukocyt
airway
lumen
pulmonari
circul
perfus
pb
remov
intravascular
leukocyt
transcript
isol
lung
analyz
wholegenom
microarray
identifi
differenti
express
gene
hour
treatment
use
fals
discoveri
rate
fdr
less
shown
gene
appli
fdr
less
figur
tabl
differenti
express
gene
upregul
rel
baselin
remain
differenti
express
hour
gene
differenti
express
hour
hour
differenti
express
gene
encod
broad
array
protein
involv
host
defens
includ
cytokin
chemokin
pattern
recognit
receptor
intracellular
signal
protein
antimicrobi
polypeptid
reactiv
oxygen
speci
gener
numer
modifi
local
host
environ
figur
tabl
geo
databas
pathway
analysi
demonstr
nfkb
signal
enrich
process
follow
close
ifnab
g
tolllik
receptor
signal
figur
engag
network
includ
pathway
import
antifung
defens
phosphatidylinositol
akt
janu
kinas
jak
signal
transduc
activ
transcript
stat
also
report
ifn
network
mitogenactiv
protein
kinas
phosphatas
tensin
homolog
pten
togeth
result
indic
rapid
broad
activ
antimicrobi
antiapoptot
pathway
within
lung
analysi
show
cytokineencod
gene
highli
upregul
individu
transcript
nthi
lysat
treatment
figur
tabl
proteinlevel
inflammatori
cytokin
concentr
also
increas
bal
fluid
treatment
increas
tnf
figur
hour
protect
respons
pamp
shown
tnfdepend
set
sought
determin
whether
nthi
lysateinduc
resist
depend
inflammatori
cytokin
use
antitnf
antibodi
previous
shown
suffici
block
inflammatori
cell
infiltr
intratrach
tnf
instil
found
differ
protect
induc
nthi
lysat
treatment
induc
rapid
pathogen
kill
figur
although
mice
increas
baselin
suscept
bacteri
infect
rel
wildtyp
mice
still
abl
induc
protect
rapid
pathogen
kill
nthi
lysat
mutant
mice
figur
therefor
although
inflammatori
cytokin
rise
dramat
stimul
may
requir
result
consist
prior
find
neutrophil
influx
parallel
induct
protect
requir
previous
postul
respiratori
epithelium
like
effector
stir
lung
investig
whether
lungexpress
antimicrobi
gene
induc
exposur
nthi
lysat
tabl
list
transcript
product
known
antimicrobi
activ
highli
upregul
nthi
treatment
previous
shown
express
lung
cell
shown
includ
broad
array
product
divers
antimicrobi
mechan
rang
direct
pathogen
kill
pathogen
opson
nutrient
sequestr
mani
product
protein
previous
note
upregul
proteom
analys
bal
fluid
nthi
lysat
treatment
induc
protect
consist
associ
rapid
substanti
reduct
pathogen
burden
infer
stir
achiev
primarili
promot
antimicrobi
environ
epitheli
cell
like
mediat
effect
base
larg
epitheli
surfac
area
lung
proxim
epithelium
pathogen
induct
epitheliumexpress
antimicrobi
gene
tabl
protein
figur
show
pretreat
respiratori
epitheli
cell
nthi
lysat
hour
substanti
reduc
pathogen
burden
cultur
media
inocul
pneumonia
b
anthraci
p
aeruginosa
figur
respect
observ
restrict
cell
rather
consist
observ
induc
bacteri
kill
varieti
murin
human
respiratori
epitheli
cell
figur
addit
mediaonli
well
ie
cell
confirm
antibacteri
effect
result
stimul
epitheli
cell
rather
intrins
antibiot
effect
lysat
fact
lysat
appear
promot
pathogen
growth
absenc
stimul
cell
figur
contrast
find
respiratori
epitheli
cell
observ
similar
induc
bacteri
kill
treat
dendrit
cell
macrophag
cell
line
nthi
lysat
figur
found
bacteri
kill
effect
stir
could
recapitul
isol
respiratori
epitheli
cell
assess
whether
occur
associ
similar
chang
gene
express
treatment
cell
nthi
lysat
pb
sham
found
induct
broad
gene
express
chang
nthi
lysatetr
cell
includ
mani
inflammatori
cytokin
induc
wholelung
model
figur
induct
inflammatori
cytokin
treatment
also
confirm
protein
level
figur
use
fdr
found
differenti
express
transcript
nthi
lysat
treatment
interv
vivo
vitro
analys
commerci
avail
illumina
sentrix
beadchip
chang
new
version
compar
wholelung
gene
express
pattern
vitro
studi
account
minor
chang
probe
set
decid
compar
bestdescrib
transcript
compar
refseqannot
transcript
induc
nthi
lysat
treatment
fdr
less
yield
common
differenti
express
transcript
chang
similar
manner
ie
either
upor
downregul
model
consid
potenti
effector
bacteri
kill
effect
look
specif
antimicrobi
peptid
tabl
total
antimicrobi
peptid
transcript
identifi
wholelung
model
also
increas
epitheli
cell
stimul
isol
tabl
five
transcript
identifi
increas
three
analys
perform
date
proteom
analysi
mous
bal
fluid
treatment
gene
express
analysi
whole
mous
lung
treatment
gene
express
analysi
epitheli
cell
vitro
chitinas
lipocalin
hemopexin
haptoglobin
calgranulin
b
show
stimul
lung
complex
mixtur
bacteri
product
result
rapid
activ
multipl
antimicrobi
pathway
activ
associ
broad
power
protect
respiratori
challeng
gramneg
bacteri
gramposit
bacteri
fungal
pathogen
mechanist
support
hypothesi
princip
mean
protect
elabor
antimicrobi
product
lung
epithelium
activ
multipl
pattern
recognit
receptor
gene
express
data
suggest
occur
nthi
lysat
treatment
result
synerg
toler
prime
interact
cellular
level
howev
whole
organ
surviv
microbi
challeng
reli
two
host
strategi
toler
abil
limit
damag
caus
pathogen
resist
abil
limit
pathogen
burden
although
previou
studi
includ
studi
endotoxin
shown
limit
resist
stimul
singl
tolllik
receptor
ligand
treatment
nthi
lysat
result
profound
protect
otherwis
lethal
pneumonia
caus
dispar
class
organ
investig
pathogen
protect
associ
signific
rapid
reduct
pathogen
burden
appli
phenomenon
descriptor
stir
pneumonia
gramneg
gramposit
fungal
pathogen
common
often
fatal
complic
among
immunocompromis
patient
use
prophylact
antibiot
prevent
infect
cultiv
microbi
antibiot
resist
caus
host
drug
toxic
previous
demonstr
protect
bacteri
pneumonia
stimul
lung
innat
immun
depend
upon
recruit
neutrophil
similarli
find
aerosol
lysat
protect
fungal
pneumonia
despit
neutrophil
suppress
cyclophosphamid
cortisol
figur
therefor
patient
undergo
myeloabl
chemotherapi
part
cancer
treatment
prepar
hematopoiet
stem
cell
transplant
might
benefit
stimul
lung
innat
immun
vulner
period
transient
sever
myelosuppress
augment
innat
immun
defens
independ
adapt
immun
function
protect
respons
induc
even
set
tcell
suppress
fludarabin
immunosuppress
calcineurin
inhibitor
alkyl
agent
nontyp
haemophilu
influenza
nthi
lysat
upregul
antimicrobi
gene
check
express
sequencetag
nation
center
biotechnolog
inform
databas
identifi
express
lung
top
lungexpress
antimicrobi
gene
shown
rank
foldchang
baselin
hour
nthi
lysat
treatment
protein
product
previous
shown
induc
nthi
lysat
exposur
anthrax
attack
unit
state
highlight
challeng
defend
popul
bioterror
agent
present
militari
personnel
first
respond
access
anthrax
vaccin
unit
state
even
adequ
vaccin
stockpil
could
maintain
antianthrax
acquir
immun
requir
month
develop
vaccin
would
protect
gener
popul
acut
furthermor
vaccin
avail
potenti
bioterror
agent
perhap
import
earli
attack
ident
pathogen
may
immedi
evid
delay
determin
appropri
prevent
andor
postexposur
therapi
therefor
broad
protect
confer
stimul
innat
immun
attract
manag
larg
popul
event
bioterror
attack
demonstr
increas
mean
surviv
everi
bioterror
pathogen
test
current
studi
provid
first
insight
cellular
effector
resist
phenotyp
lung
wherea
neutrophil
mast
cell
alveolar
macrophag
expend
nthi
lysateinduc
protect
show
vitro
respiratori
epitheli
cell
suffici
sens
treatment
gener
antimicrobi
respons
direct
contact
treatment
close
apposit
deposit
pathogen
establish
capac
gener
antimicrobi
product
respiratori
epithelium
seem
well
suit
serv
stir
effector
function
vivo
although
strongli
upregul
gene
treatment
encod
cytokin
common
mediat
inflamm
tnf
requir
induc
resist
consist
previou
find
neutrophil
infiltr
requir
protect
hand
proteom
genom
tabl
analys
indic
respiratori
epithelium
express
numer
antimicrobi
product
respons
nthi
lysat
treatment
gene
express
analys
identifi
sever
intrigu
stir
candid
mediat
three
known
mous
acutephas
serum
amyloid
saa
gene
compris
three
four
highli
upregul
lung
antimicrobi
gene
vivo
nthi
lysat
treatment
enigmat
apolipoprotein
promot
host
defens
wide
vari
mechan
includ
cathelicidinlik
direct
kill
pathogen
opson
induct
leukocyt
chemotaxi
although
significantli
upregul
vitro
array
notabl
two
transcript
higher
time
point
vivo
studi
possibl
observ
maxim
express
hour
also
upregul
lipocalin
orosomucoid
orosomucoid
lipocalin
recent
shown
critic
host
defens
bacteri
pathogen
protect
function
seem
result
mainli
iron
sequestr
although
lipocalin
also
appear
key
defens
respiratori
epithelium
lipocalin
one
five
antimicrobi
effector
found
upregul
proteom
gene
express
screen
nthi
lysat
treatment
make
interest
candid
howev
seen
similarli
broad
robust
protect
previou
studi
address
antimicrobi
effect
lipocalin
therefor
suspect
lipocalin
particip
nthi
lysateinduc
stir
probabl
one
sever
antimicrobi
effector
saa
protein
lipocalin
antimicrobi
product
identifi
analys
care
explor
potenti
effector
may
play
differ
role
differ
pathogen
investig
identifi
novel
nthiinduc
antimicrobi
effector
also
underway
well
explor
possibl
effector
mechan
augment
barrier
function
serum
amyloid
antimicrobi
transcript
upregul
tabl
evalu
murin
lung
epitheli
cell
hour
treatment
mgml
nontyp
haemophilu
influenza
lysat
upregul
transcript
shown
candid
effector
identifi
proteom
screen
bal
fluid
wholelung
gene
express
analysi
vitro
gene
express
analysi
figur
broad
induct
gene
express
chang
nthi
lysatetr
respiratori
epitheli
cell
cell
treat
mgml
nthi
lysat
hour
rna
harvest
analyz
treatmentinduc
gene
express
chang
total
differenti
express
transcript
identifi
red
increas
gene
express
green
decreas
gene
express
includ
mani
inflammatori
cytokin
found
upregul
wholelung
model
b
chang
confirm
protein
level
ce
cytokin
level
report
mean
p
p
whether
stir
pure
epitheli
phenomenon
lung
remain
seen
found
epitheli
cell
isol
stimul
kill
bacteria
associ
gene
express
pattern
cytokin
elabor
similar
note
whole
lung
system
support
hypothesi
epithelium
critic
stir
strike
contrast
macrophag
dendrit
cell
could
stimul
lysat
directli
kill
extracellular
bacteria
vitro
figur
consist
prior
find
macrophag
requir
vivo
stir
nonetheless
dendrit
cell
may
sens
stimulu
vivo
reinforc
epitheli
effector
respons
local
signal
via
mechan
summari
demonstr
stimul
lung
innat
immun
provid
protect
remark
breadth
respiratori
pathogen
therapeut
manipul
stir
may
possibl
reduc
burden
respiratori
infect
immunosuppress
patient
reduc
risk
infect
gener
public
bioterror
attack
pathogen
introduc
via
respiratori
rout
conflict
interest
statement
mh
cofound
pulmotect
inc
own
share
compani
receiv
research
grant
compani
dk
reimburs
merck
pfizer
enzon
astella
total
particip
speaker
andor
lectur
variou
meet
symposium
confer
advisori
board
meet
also
receiv
industri
grant
astella
merck
excess
cgc
mjt
bfd
inventor
subject
matter
disclos
patent
applic
composit
method
stimul
lung
innat
immun
file
board
regent
univers
texa
system
none
author
financi
relationship
commerci
entiti
interest
subject
manuscript
